Winquist, Eric

Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy

Ryan, C. J., Smith, M. R., de Bono, J. S., Molina, A., Logothetis, C. J., de Souza, P., Fizazi, K., Mainwaring, P., Piulats, J. M., Ng, S., et al. (2013) · New England Journal of Medicine

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 2,796

Exemestane for Breast-Cancer Prevention in Postmenopausal Women

Goss, P. E., Ingle, J. N., Alés-Martínez, J. E., Cheung, A. M., Chlebowski, R. T., Wactawski-Wende, J., McTiernan, A., Robbins, J., Johnson, K. C., Martin, L. W., et al. (2011) · New England Journal of Medicine

Estrogen and related hormone effectsBreast Cancer Treatment Studies

Cited by 970

Systemic Therapy in Men With Metastatic Castration-Resistant Prostate Cancer: American Society of Clinical Oncology and Cancer Care Ontario Clinical Practice Guideline

Basch, E., Loblaw, D. A., Oliver, T. K., Carducci, M., Chen, R. C., Frame, J. N., Garrels, K., Hotte, S., Kattan, M. W., Raghavan, D., et al. (2014) · Journal of Clinical Oncology

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 223

Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care

Miller, F. A., Hayeems, R. Z., Bytautas, J. P., Bedard, P. L., Ernst, S., Hirte, H., Hotte, S., Oza, A., Razak, A., Welch, S., et al. (2014) · European Journal of Human Genetics

BRCA gene mutations in cancerCancer Genomics and Diagnostics

Cited by 116

Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer

Ghasemi, F., Black, M., Vizeacoumar, F., Pinto, N., Ruicci, K. M., Le, C. C. S. H., Lowerison, M. R., Leong, H. S., Yoo, J., Fung, K., et al. (2017) · Oncotarget

Head and Neck Cancer StudiesHistone Deacetylase Inhibitors Research

Cited by 38